Saturday, July 12, 2025

Latest

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market yesterday under the symbol “DICE”. The firm’s initial public offering is looking to raise US$204.0 million and is expected to close on September 17, 2021.

The offering will be conducted through the issuance of 12.0 million common shares selling at US$17.00 per share. This is an adjustment from the company’s original plan to issue 10.0 million shares with share price expectations between US$15.00 and US$17.00.

The company granted the underwriters a 30-day over-allotment option to purchase additional 1.8 million common shares at the same IPO price, potentially bringing proceeds up to US$82.8 million. BofA Securities, SVB Leerink, and Evercore ISI are all acting as joint bookrunners for the said offering.

The California-based biotech firm is in the business of developing immunotherapies for patients with chronic diseases. Currently, the firm’s lead therapeutic candidate S011806 is an oral antagonist targeting a pro-inflammatory signaling molecule connected with a variety of immunology indications. The orally-available candidate is expected to enter its phase 1 trial in the second half of 2021.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Mergers Set the Stage for Uranium’s Growth Cycle | Forum-Baselode Merger

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Recommended

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

Related News

Squarepace: The IPO Deep Dive

If you’re a business looking to have an online presence, you might have tried creating...

Tuesday, May 18, 2021, 01:30:00 PM

Robinhood Stock Falls in First Trading Day After IPO; Still Looks Richly Valued

Robinhood Markets Inc. (NASDAQ: HOOD), the popular online brokerage which pioneered zero commissions for retail...

Friday, July 30, 2021, 02:32:00 PM

Real Estate-Focused Fintech SPAC Southport Acquisition Prices US$200 Million IPO

Special purpose acquisition company Southport Acquisition Corporation (NYSE: PORT.U) went public on Friday at the...

Monday, December 13, 2021, 02:19:00 PM

Renewable Energy SPAC AP Acquisition Prices US$150 Million IPO

Special purpose acquisition company AP Acquisition Corp (NYSE: APCA.U) went public today on the New...

Friday, December 17, 2021, 02:23:00 PM

Eagle Equity’s 8th SPAC Screaming Eagle Acquisition Prices US$750 Million IPO

Special purpose acquisition company Screaming Eagle Acquisition Corp.(Nasdaq: SCRMU) started trading publicly on the Nasdaq...

Thursday, January 6, 2022, 02:18:00 PM